NCT06093971Completed
Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy
Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy: A Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 12 Dec 2024
Brief summary (registry, in English)
The investigators conduct a random assignment into either the remimazolam group or the propofol group. Depending on the group assignment, either remimazolam (0.2 mg/kg) or propofol (1.0 mg/kg) is administered. If necessary, additional doses of remimazolam (0.1 mg/kg) or propofol (0.5 mg/kg) are given. The standard anesthesia procedure of our institution is followed, and blood pressure data recorded during the surgery is analyzed (mean arterial pressure \<65mmHg is defined as hypotension).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 112 (actual)
- First submitted
- 12 Sept 2023
- Start date
- 17 Nov 2023
- Primary completion date
- 22 Oct 2024
- Lead sponsor
- Yonsei University
- Diseases
- Prostate cancer
- NCT number
- NCT06093971
What you commit to
- Study type: Interventional
- Participants enrolled: 112
- From 17 Nov 2023 to the primary completion date, 22 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- emergency surgery
- Patients who did not take renin-angiotensin system blockers on the day of surgery
Lab values
- Atrial fibrillation, moderate to severe valvular disease, ejection fraction of 35% or less
Other
- If the subject includes those who cannot read the consent form (e.g. illiterate, foreigners, etc.)
- cognitive dysfunction
Who the study is looking for
- Patients who undergo robot-assisted laparoscopic prostatectomy and who have taken renin-angiotensin system blockers for more than 3 months.
Age in the registry: 19 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yonsei University College of Medicine Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.